Merger Arbitrage Blog

Tesaro Engaged Banks as Suitors Circle

Tesaro rosed sharply 14% yesterday after news reports said that suitors such as Sanofi are seeking to buy the biotech company and that the company is speaking with banks for advice. Tesaro’s PARP inhibitor niraparib is seen as a potential blockbuster and giant biotech and pharma firms pressed to increase revenue are hardpressed to find another such target with a soon to be approved blockbuster.

Updated: February 9, 2017 — 3:06 pm

Leave a Reply

Your email address will not be published. © 2016 Frontier Theme